Sanofi to Buy Synthorx for $2.5 Billion




 

Dec.09 -- M&A Monday has begun with another big deal in the biotech space. Sanofi has agreed to buy U.S.-based Synthorx in a buyout worth approximately $2.5 billion. Bloomberg's Sarah Syed reports on "Bloomberg Markets: European Open."

COMMENTS

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Economy